#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Modern Treatment of Schizophrenia

We recommend Anatomie lidského srdce

Metabolická a kardiovaskulární rizika u pacientů se schizofrenií

29. 1. 2021 Source: Modern Treatment of Schizophrenia

Pacienti se schizofrenií mají oproti obecné populaci vyšší prevalenci kardiometabolických (KM) rizikových faktorů, což přispívá k jejich vyšší mortalitě. Vedle vrozených dispozic, nezdravého životního stylu a snížené dostupnosti lékařské péče může KM riziko zvyšovat rovněž antipsychotická léčba. Psychiatr může ke snížení tohoto rizika přispět monitorováním tělesného zdraví svých pacientů a případnou léčbou ve spolupráci s dalšími specialisty a také výběrem méně rizikového antipsychotika.

Pacient schizofrenie_léky

Improvement in social functioning of patients with schizophrenia during treatment with lurasidone

A beneficial impact on social functioning is an important outcome of schizophrenia treatment. A…
19. 3. 2024 Source: Modern Treatment of Schizophrenia
obezita_váha

Causes, Consequences, and Solutions to Weight Gain in Schizophrenia Treatment

The use of antipsychotics in the treatment of schizophrenia is often associated with the…
13. 3. 2024 Source: Modern Treatment of Schizophrenia

Articles on this topic
metabolický syndrom

Tool for Predicting Cardiometabolic Risk in Young Patients with Psychotic Disorder

A study describing the development and validation of an algorithm for predicting…
13. 12. 2022 Source: Modern Treatment of Schizophrenia
Antipsychotika

Meta-analysis of the Metabolic Effects of Second-generation Antipsychotics

Second-generation antipsychotics used in the therapy of schizophrenia exhibit varying…
1. 11. 2022 Source: Modern Treatment of Schizophrenia
metabolický syndrom

Prevalence of Metabolic Syndrome During 1 Year After the First Episode of Psychosis

Portuguese authors elucidated the high prevalence of metabolic syndrome and adverse metabolic…
1. 11. 2022 Source: Modern Treatment of Schizophrenia
Obézní dítě

Lurasidone in the Treatment of Adolescent Schizophrenia: How Does It Compare with Other Atypical Antipsychotics?

A meta-analysis of 13 studies comparing lurasidone with other atypical antipsychotics in…
27. 9. 2022 Source: Modern Treatment of Schizophrenia
kardiometabolická onemocnění

Transition from Risperidone to Lurasidone and Adjustment of Metabolic Profile in Patients with Stable Schizophrenia

Patients with schizophrenia have a higher risk of cardiometabolic diseases compared to the…
27. 9. 2022 Source: Modern Treatment of Schizophrenia
Muž_deprese

Lurasidone in Antipsychotic Therapy – A Case Study of a Virtual Patient from the Laurie Project

MUDr. Elis Bartečků, Ph.D., from the Department of Psychiatry at MU LF and FN Brno presented…
18. 8. 2022 Source: Modern Treatment of Schizophrenia
obezita a deprese

Complex Impacts of Obesity on the Brains of People with Psychiatric Disorders

Obesity in individuals with bipolar disorder or schizophrenia is closely linked not only to…
18. 8. 2022 Source: Modern Treatment of Schizophrenia
Psychiatr_mladá žena

Psychiatry of Transitional Age − An Important Area That Has Not Yet Received Much Attention

Three-quarters of psychiatric disorders develop before the age of 25, with up to half of these…
19. 5. 2022 Source: Modern Treatment of Schizophrenia
Schizofrenie_žena

Modern View on Schizophrenia Therapy Through the Lens of Lurasidone

At the psychiatric symposium titled 'Chance for a Better Quality of Life with a Schizophrenia…
14. 12. 2021 Source: Modern Treatment of Schizophrenia
Schizofrenie_muž

Treatment of Schizophrenia in Light of New Findings

"Mental disorders constitute a significant burden on society," began Assoc. Prof. MUDr. Martin…
14. 12. 2021 Source: Modern Treatment of Schizophrenia

1 2 3 4
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#